Vitamin D Testing Market Analysis
The Vitamin D Testing Market is expected to register a CAGR of 5.1% during the forecast period.
Vitamin D Testing Market Trends
25-Hydroxy Vitamin D Test is Anticipated to Dominate the Market During the Study Period
25-hydroxy vitamin D test is considered the most accurate way to detect the level of vitamin D in a person. According to an article published by Icahn School of Medicine at Mount Sinai in April 2022, it was stated that 25-hydroxy vitamin D test is considered the most precise way to determine the vitamin D level in the body. Also, according to an article published by Healthline Media in January 2022, it was stated that the amount of 25 OH vitamin D is an important indicator to detect osteoporosis and rickets.
Additionally, certain benefits, including longer shelf life of 25 OH vitamin D over 1,25 dihydroxy vitamin D, are poised to fuel the adoption of this segment during the study period. For instance, according to an article by NCBI in September 2022, it was reported that owing to the extended half-life of 2 weeks for 25-hydroxy vitamin D, it is mostly recommended for the detection of vitamin D levels in the body as opposed to 1,25 dihydroxy vitamin D, which has a half-life of fewer than 4 hours.
Apart from that, an increasingly sedentary lifestyle decreases exposure to sunlight, and a lower intake of green vegetables and fruits results in a reduced amount of vitamin D in the human body. For instance, according to an article published by HealthifyMe in June 2022, it was stated that several factors, including the primary reason for vitamin D deficiency, is attributed to lack of exposure to sunlight. Also, according to a cross-sectional study conducted in India and published by Informa UK Limited in 2020, it was reported that the prevalence of vitamin D deficiency was found to be around 65.5% among obese patients. This resulted in an increased patient pool suffering from vitamin D deficiency disorders which in turn increased the adoption of the 25-hydroxy vitamin D test during the study period.
In addition to that, a wide range of product availability for the 25-hydroxy vitamin D test is augmenting the adoption rate of this test kit and assay technology among physicians and the general population. For instance, in March 2020, Thermo Fisher Scientific Inc. announced the availability of the Cascadion SM Clinical Analyzer in the United States for 25-hydroxy vitamin D assay testing.
Therefore, the reasons mentioned above are the primary driving factors for the lion's share of the segment in the market during the study period.
North America is Anticipated to Dominate the Vitamin D Testing Market
North America is expected to dominate the market owing to primary factors, including the rising prevalence of vitamin D deficiency and the rising number of product approvals for vitamin D test kits by the U.S. FDA in the United States. For instance, according to data published by Cleveland Clinic in August 2022, an estimated 35% of adults in the United States suffer from vitamin D deficiency. This augments the demand and adoption of diagnostic kits in this region and alternatively fuels regional growth during the study period.
Additionally, to increase awareness of the nutritional value of vitamin D, several organizations are organizing awareness campaigns in the United States. For instance, in August 2020, the Organic & Natural Health Association initiated an educational campaign to enlighten the health benefits of vitamin D. This increased the demand and adoption of vitamin D testing among the general population and subsequently supported the growth of the market in this region.
Apart from that, the availability of favorable reimbursement policies for certain vitamin D tests and increasing awareness among the general population on vitamin D tests is poised to increase the adoption of vitamin D tests in a large proportion. According to UnitedHealthcare Medicare Advantage Policy Guideline in April 2022, it was stated that if the vitamin D level is less than 20 ng/dl or greater than 60 ng/dl, a certain amount of the expense will be reimbursed in the United States.
Therefore, owing to the above-mentioned factors, the North America region is anticipated to lead the regional share during the forecast period.
Vitamin D Testing Industry Overview
The Vitamin D Testing Market is consolidated in nature due to the presence of a few major players dominating the market shares. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. include F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., Abbott, bioMérieux SA, Siemens Healthcare GmbH, Beckman Coulter, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Thermo Fisher Scientific Inc., Tosoh Bioscience, Inc., Qualigen Therapeutics Inc., among others.
Vitamin D Testing Market Leaders
-
F. Hoffmann-La Roche Ltd.
-
DiaSorin S.p.A.
-
Abbott
-
Siemens Healthcare GmbH
-
Thermo Fisher Scientific Inc.
- *Disclaimer: Major Players sorted in no particular order
Vitamin D Testing Market News
- April 2022: Empower Clinics Inc., introduced the Vitamin D Rapid Testing Kit under the Medisure brand to cater to the rising demand for vitamin D tests in Canada.
- November 2020: OmegaQuant introduced a Vitamin D Test with sample collection kits in the U.S. that assist the patient to test the vitamin level at home.
Vitamin D Testing Industry Segmentation
As per the scope of the report, the Vitamin D Test assists in detecting the vitamin D level in the human body.
The Vitamin D Testing Market is segmented by Test Type (25-Hydroxy Vitamin D Test, and 1,25 Dihydroxy Vitamin D Test), End-User (Hospitals & Clinics, Diagnostics Labs, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, worldwide. The report offers the value (USD million) for the above segments.
By Test Type | 25-Hydroxy Vitamin D Test | ||
1,25 Dihydroxy Vitamin D Test | |||
By End-User | Hospitals & Clinics | ||
Diagnostics Labs | |||
Other End-Users | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle-East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Vitamin D Testing Market Research FAQs
What is the current Vitamin D Testing Market size?
The Vitamin D Testing Market is projected to register a CAGR of 5.1% during the forecast period (2025-2030)
Who are the key players in Vitamin D Testing Market?
F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Abbott, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc. are the major companies operating in the Vitamin D Testing Market.
Which is the fastest growing region in Vitamin D Testing Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Vitamin D Testing Market?
In 2025, the North America accounts for the largest market share in Vitamin D Testing Market.
What years does this Vitamin D Testing Market cover?
The report covers the Vitamin D Testing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Vitamin D Testing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Vitamin D Testing Industry Report
Statistics for the 2025 Vitamin D Testing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vitamin D Testing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.